Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 270-185-2 | CAS number: 68412-38-4 This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77899.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Bacteria:
According to OECD 471; non-GLP; TA1535, TA1537, TA98, TA100; concentrations 20, 100, 500, 2500 and 5000 ug/ plate; not mutagenic (unpublished data, 1985)
Gene mutation:
RA: OECD 476; GLP; L5178Y cells; 3.13, 6.25, 12.5, 25, 50, 100 µg/ml; not mutagenic (1996)
Chromosome aberration:
RA: OECD 487; GLP; CHL V79 cells; range 0.078 to 25 µg/ml; not clastogenic or aneugenic (2001)
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- (missing tester strain to detect crosslinking/oxidising agents, non-GLP)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Remarks:
- missing tester strain to detect crosslinking/oxidising agents according to latest OECD 471 guideline
- Principles of method if other than guideline:
- Standard plate test (repeated with identical concentrations)
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- his-
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- induced rat liver S-9 mix
- Test concentrations with justification for top dose:
- 0, 20, 100, 500, 2500 and 5000 ug/ plate
- Vehicle / solvent:
- DMSO
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- other: with S-9 mix: 10 ug 2-aminoanthracene (all strains); without S-9 mix: 5 ug N-methyl-N'-nitro-N-nitroso-guanidine for the strains TA 100 and TA 1535; 10 ug 4-nitro-o-phenylenediamine for the strain TA 98; 100 ug 9-aminoacridine chloride monohydrate for t
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
NUMBER OF REPLICATIONS: 3 - Evaluation criteria:
- In general, a substance to be characterized as positive in the Ames test has to fulfill the following requirements:
- doubling of the spontaneous mutation rate (control)
- dose-response relationship
- reproducibility of the results. - Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- Complete solubility of the test substance in DMSO.
- Conclusions:
- Not mutagenic under the conditions of the test.
- Endpoint:
- genetic toxicity in vitro, other
- Remarks:
- cytogenicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- See read-across justification
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Guideline:
- OECD Guideline 487 (In vitro Mammalian Cell Micronucleus Test)
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosomal Aberration Test)
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- See read-across justification attached to IUCLID section 13.2
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
Referenceopen allclose all
1st Standard Plate Test | |||||
Solvent: DMSO | |||||
Strain | Metabolic activation system | Replicates | maximum revertant factor | dose dependency | Assessment |
TA 1535 | no | 3 | 1.2 | yes | negative |
yes | 3 | 1.3 | no | negative | |
TA 100 | no | 3 | 1.1 | no | negative |
yes | 3 | 1.1 | no | negative | |
TA 1537 | no | 3 | 1.3 | no | negative |
yes | 3 | 1.4 | no | negative | |
TA 98 | no | 3 | 1.1 | no | negative |
yes | 3 | 1.0 | no | negative | |
2nd Standard Plate Test | |||||
Solvent: DMSO | |||||
Strain | Metabolic activation system | Replicates | maximum revertant factor | dose dependency | Assessment |
TA 1535 | no | 3 | 1.0 | no | negative |
yes | 3 | 1.3 | no | negative | |
TA 100 | no | 3 | 1.1 | no | negative |
yes | 3 | 1.0 | no | negative | |
TA 1537 | no | 3 | 0.9 | no | negative |
yes | 3 | 1.1 | no | negative | |
TA 98 | no | 3 | 1.1 | no | negative |
yes | 3 | 1.1 | no | negative |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In vitro
For the gene mutagenicity in bacteria, two valid studies were available, which were both performed according to OECD TG 471 but did not follow GLP requirements (unpublished data, 1985a, 1985b). Both studies were performed as repeated standard plate tests with S. typhimurium strains TA1535, TA1537, TA98 and TA100 with or without metabolic activation up to 5000 µg/plate; a strain to detect crosslinking/ oxidising agents was not included in the studies. In one study, TA1535 produced equivocal results without metabolic activation. In the test repeat and the complete other study, TA1535 produced negative results. All other strains were negative, too. Since not all evaluation criteria (maximum revertant factor >2, repeatable result) were fulfilled, the substance was assessed to be negative under the conditions of the test.
Additionally, in vitro gene mutation and chromosome aberration studies were conducted with two analogue substances, namely Pigment Yellow 53 (CAS 8007-18-9) and Pigment Brown 24 (CAS 68186-90-3). Detailed information are presented subsequently.
Pigment Yellow 53 (CAS 8007-18-9) was used in a study performed as plate incorporation tests with S. typhimurium strains TA 98, TA 100, TA 1535, TA 1537, TA 1538 and E. coli WP2 uvrA with or without metabolic activation up to 5000 µg/plate. All strains gave negative results, thus giving no indication for a mutagenic potential of the test substance (unpublished data 1995a, OECD 471, GLP). In addition, Pigment Yellow 53 was used to expose L5178Y cells to concentrations of 3.13, 6.25, 12.5, 25, 50 and 100 µg/mL (suspension with DMSO) in the presence and absence of mammalian metabolic activation (Aroclor-induce rat liver (S9)). None of the six analyzed treatments with or without metabolic activation induced a mutant frequency that exceeded the minimum criterion for a positive response. Thus, the test substance was concluded to have no mutagenic potential under the conditions chosen (unpublished data, 1996, OECD 476, GLP).
Chinese hamster lung cells (CHL/IU) were exposed to Pigment Yellow 53 at concentrations ranging from 9.79 to 78.1 μg/mL with and without metabolic activation. No increase in chromosomal aberrations was observed in the test neither with the short-term treatment (-S9 mix and +S9 mix) nor the continuous treatment. Thus, the test substance was concluded to not be clastogenic (unpublished data, 2001a, OECD 473, GLP).
Pigment Brown 24 (CAS 68186-90-3) was tested in an Ames assay. The tester strains used were S. typhimurium strains TA98, TA100, TA1535, TA1537, TA 1538 and the E. coli tester strain WP2 uvrA. The strains were exposed to concentrations of 100, 250, 500, 1000, 2500 and 5000 µg/plate in the presence and absence of S9 mix. The test substance did not cause a positive increase in the number of revertants per plate of any of the tester strains either in the presence or absence of S9 mix (unpublished data, 1995b, OECD 471, GLP). In addition, Pigment Brown 24 was tested with mouse lymphoma cells using concentrations (suspension in DMSO) of 3.13, 6.25, 12.5, 25.0, 50.0 and 100 µg/mL in the presence and absence of rat liver S9 metabolic activation. None of the six analyzed treatments with or without metabolic activation included a mutation frequency that exceeded the minimum criterion for a positive response. Thus, the test substance was negative (unpublished data, 1996, OECD 476, GLP).
CHL V79 cells were exposed to concentrations of Pigment Brown 24 in the range of 0.078 and 25 µg/ml. Strong test substance precipitation in the vehicle was observed at all test doses. In culture the test substance was obviously soluble up to 6.25 µg/mL. The test substance did not cause any increase in the number of cells containing micronuclei either without S-9 mix or after adding a metabolizing system. Thus, the test substance is neither clastogenic nor aneugenic under the conditions chosen (unpublished data, 2001, OECD 487, GLP).
Taking all information together, the target substance is not expected to be mutagenic in bacteria or mammalian cells and is not assumed to be clastogenic or aneugenic.
In vivo
There is no positive result from any in vitro study performed. An in vivo study is therefore not considered to be appropriate according to Regulation (EC) No 1907/2006, Annex IX, 8.4.
Justification for classification or non-classification
Classification, Labeling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result, the substance is not considered to be classified for genotoxicity under Regulation (EC) No. 1272/2008, as amended for the thirteenth time in Regulation (EC) 2018/1480 of 4 October 2018.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.